US 10973813
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted A61KA61K31/4745A61K31/497
Quick answer
US patent 10973813 (Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/4745, A61K31/497, A61K31/506, A61K31/5377